Phoenix Copper Limited (PXCLY)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	May 16, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	11	12	34	42	84	34
Market Cap Growth	-63.45%	-63.45%	-19.70%	-50.03%	146.81%	342.77%
Enterprise Value	16	16	33	33	65	33
Last Close Price	0.41	0.51	3.42	3.10	7.70	-
PB Ratio	0.27	0.30	0.91	1.11	2.23	2.47
P/TBV Ratio	0.27	0.31	0.92	1.13	2.26	2.54
Debt / Equity Ratio	0.14	0.14	0.06	-	-	0.11
Quick Ratio	0.95	0.95	0.25	4.54	11.75	0.70
Current Ratio	1.47	1.47	0.65	5.80	11.89	0.73
Return on Equity (ROE)	-16.06%	-16.06%	-4.20%	-4.16%	-3.75%	-7.97%
Return on Assets (ROA)	-2.27%	-2.27%	-2.48%	-1.58%	-2.13%	-4.01%
Return on Capital (ROIC)	-2.34%	-2.34%	-2.58%	-1.66%	-2.26%	-4.31%
Earnings Yield	-55.81%	-50.37%	-4.54%	-3.67%	-1.12%	-2.80%
FCF Yield	-71.22%	-64.27%	-19.43%	-20.60%	-12.61%	-9.98%
Buyback Yield / Dilution	-37.31%	-37.31%	-1.39%	-16.87%	-81.15%	-40.78%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.